| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |